Pompano Beach, Fla., Jan. 11, 2016 (GLOBE NEWSWIRE) --
DS Laboratories is pleased to announce new distribution at leading online retailers in both China and the US. These are two focus markets for DS Healthcare in 2016 and will enable a whole new group of consumers to conveniently access DS Healthcare products from the comfort of their home.
DS Laboratories expects these distribution platforms to be extended with additional products from the DS existing portfolio and/or select products from the 20 exclusive brands they are acquiring through the asset acquisition of W/R Group, Inc. Hero products from each brand or sub-brand may be introduced on a rotating basis to service the marketplace’s desire for the treasure hunt experience of finding innovative products that offer an extremely high value proposition to the home shopper.
“We have partnered with JD.com (Nasdaq: JD) and VIP.com (Nasdaq: VIPS) in China and Costco.com in the US with a curated selection of our high-quality hair growth products under our premium master brand, DS Laboratories,” stated Renee Barch-Niles, CEO. “According to online research data, JD.com is the second largest e-commerce platform in China that currently has 131.9 million active customers accounting for $18.5 billion dollars of revenue in 2014. VIP.com is a top four online retailer with 14.6 million highly loyal consumers that make an average of 3.1 purchases annually from VIP.com. And finally, Costco.com, a leading US retailer, markets to over 50 million loyal shoppers that prefer premium retail stores such as Sephora, Neiman Marcus and Nordstrom. These are specific, pre-qualified shoppers seeking higher-end, exclusive products that meet our targeted demographic. These three platforms alone—along with our highly targeted marketing campaigns supporting these launches—will bring awareness of the DS Laboratories brand to millions of new customers.”
Manny Gonzalez, CCO, added, “Broad exposure for our Revita and Spectral product lines, under our flagship DS Laboratories brand, will also drive people into the high-end pharmacies and salons in which we distribute in these countries. The credibility that these platforms bring to millions of customers will provide additional education and awareness to those consumers who are actively seeking results-oriented, superior products that only DS Laboratories can provide to address their hair health needs and concerns.”
About DS Healthcare Group
DS Healthcare Group Inc. develops novel biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Healthcare Group's flagship brand, visit www.dslaboratories.com.
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
Contact Investor Relations DS Healthcare Group (888) 404-7770 ext. 3 Investors@DSHealthgroup.com
Source:DS Healthcare Group, Inc.